Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural diseases.

R W Light1

  • 1University of California, Irvine.

Disease-A-Month : DM
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

This study differentiates transudative and exudative pleural effusions, common conditions affecting one million Americans annually. Understanding their causes and diagnostic markers like protein and lactic dehydrogenase (LDH) levels is crucial for effective patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.

Lymphology·2018
Same author

Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).

Canadian respiratory journal·2017
Same author

Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).

Lung·2015
Same author

Research: Why and how to write a paper?

Revista clinica espanola·2015
Same author

Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2012
Same author

Drug-induced eosinophilic pleural effusion.

European respiratory review : an official journal of the European Respiratory Society·2011
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Pulmonology
  • Internal Medicine
  • Pathophysiology

Background:

  • Pleural effusions affect approximately one million patients annually in the U.S.
  • Classically divided into transudative and exudative types based on underlying causes.
  • Distinguishing between these types is essential for appropriate diagnosis and treatment.

Purpose of the Study:

  • To delineate the etiological factors differentiating transudative and exudative pleural effusions.
  • To outline diagnostic criteria for distinguishing between the two effusion types.
  • To summarize management strategies for specific causes of pleural effusions.

Main Methods:

  • Classification of pleural effusions into transudative and exudative categories.
  • Analysis of systemic versus local factors influencing pleural fluid accumulation.

Related Experiment Videos

  • Utilizing pleural fluid protein and lactic dehydrogenase (LDH) levels for differentiation.

    • Main Results:

    • Transudative effusions linked to systemic factors (e.g., left ventricular failure, cirrhosis).
    • Exudative effusions associated with local factors (e.g., pneumonia, malignancy, pulmonary embolism).
    • Diagnostic criteria include ratios of pleural fluid to serum protein (<0.5) and LDH (<0.6), and absolute LDH levels.

    Conclusions:

    • Pleural effusion diagnosis relies on differentiating transudative and exudative causes.
    • Key diagnostic markers include protein and LDH levels in pleural fluid.
    • Management strategies vary based on the underlying etiology, ranging from medical treatment to surgical interventions.